Skip to main content

Spotlight on Oncology Nutrition

February 1, 2017

Jennifer Spring currently serves as an oncology dietitian in the Outpatient Oncology Nutrition Program at the NC Cancer Hospital in Chapel Hill, North Carolina. In this role, Jennifer works with patients to develop individualized eating plans to meet specifics needs or concerns related to cancer prevention, treatment, and recovery. Jennifer is a 2016 UNC Oncology Excellence Award recipient. I recently had the pleasure of interviewing Ms. Spring regarding a study on the health benefits of certain mushrooms (Click on the headline to read the full article).

New UNCCN Team Member!

February 1, 2017

Please join us in welcoming Veneranda Joseph Obure as the UNC Cancer Network’s new AV Support Engineer. (Please click on the headline to read the full article).

Spotlight on FDA-Approved Optune Device to Treat Glioblastoma

February 1, 2017

The Optune device is a portable FDA-Approved device designated to treat glioblastoma (GBM). GBM is an aggressive tumor that forms in the tissue of the brain and spinal cord, according to the American Brain Tumor Association. Today, GBM is increasingly common. With Senator John McCain recently being diagnosis with having glioblastoma, this disease has been the topic of discussion, more now than ever. Dr. Simon Khagi is the director of the UNC Brain Tumor Program and is using the Optune device to treat his patients. According to Dr. Khagi, the state of North Carolina has 500 GBM cases per year. I was recently granted a brief opportunity to talk with Dr. Khagi and ask a few questions about the device and how it is being used to help his patients at UNC (Click on the title of the article to read the interview and learn more).

New Physician at UNC

February 1, 2017

Please join us in welcoming Dr. Joan D. Beckman, MD, PhD to UNC as a Clinical Instructor in Hematology. (Please click on the headline to read the full article).

Two New Physicians at UNC!

February 1, 2017

Please join us in welcoming two new physicians to the UNC Lymphoma Program. (Please click on the headline to read the full article).